The phase 3b STEP UP obesity trial in more than 1,400 patients compared a 7.2mg weekly subcutaneous injection of semaglutide to the standard 2.6mg weekly dose sold as Wegovy or a matched placebo over 72 weeks
Specifically, the group receiving retatrutide had significantly improved levels of kidney function parameters, as well as lower expression of inflammatory and fibrotic biomarkers in renal tissue
& de la Fuente, L
Then using your 3 mL syringe, draw up 1 mL of Sterile Water for Injection into the syringe (this amount can vary, so refer back to your prescription)
Stacking them targets two different rate-limiting steps at once
Europe is expected to grow at a significant CAGR during the forecast period, driven by the support provided by obesity management policies, the quality of public healthcare systems, and the rising awareness of cardiovascular and metabolic health benefits of GLP-1 analogues